Changes of the Heart Rhythm in Imbalance of Thyroid Gland Hormones and its Morphology in Outbred Rats

Aim. To analyze the relationship between the occurrence of atrial fibrillation (AF) and thyroid dysfunction caused by low concentrations of free triiodothyronine (FT3), free triiodothyronine and free thyroxine (FT3 and FT4), and high concentrations of free thyroxine (FT4) with normal values of thyroid-stimulating hormone (TSH) in experiments on outbred rats.
Material and methods. The pathogenesis of AF with low concentrations of FT3, FT3 and FT4, and a high concentration of FT4 was studied in an experiment on 146 outbred rats. In the experiment, hypothyroidism, euthyroidism, and thyrotoxicosis were modeled by changing the concentrations of thyroid hormones, and the effect of these conditions on ECG and the incidence of AF was evaluated.
Results. The types of the hypothalamic-pituitary-thyroid system response to the L-thyroxine administration in experimental hypothyroidism were identified. A relationship was determined between AF paroxysms and threshold values of thyroid hormones at low concentrations of FT3, FT3 and FT4, and a high concentration of FT4 with normal TSH values. It was shown that achieving the euthyroid status did not reduce the incidence of AF paroxysms by more than 70.0%.
Conclusion. In AF with low FT3, low FT3 and FT4, and high FT4, the dose of L-thyroxine must be adjusted.

1. Takawale A, Aguilar M, Bouchrit Y, Hiram R. Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis. Cells. 2022;11(24):4047. DOI: 10.3390/cells11244047

2. Bekiaridou A, Kartas A, Moysidis DV, Papazoglou AS, Baroutidou A, Papanastasiou A et al. The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations. Reviews in Endocrine and Metabolic Disorders. 2022;23(3):621–30. DOI: 10.1007/s11154-022-09713-0

3. Anderson JL, Jacobs V, May HT, Bair TL, Benowitz BA, Lappe DL et al. Free thyroxine within the normal reference range predicts risk of atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2020;31(1):18–29. DOI: 10.1111/jce.14183

4. Vasilopoulou A, Patsiou V, Bekiaridou A, Papazoglou AS, Moysidis DV, Spaho M et al. Prognostic implications of thyroid disease in patients with atrial fibrillation. Heart and Vessels. 2024;39(2):185–93. DOI: 10.1007/s00380-023-02341-x

5. Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH et al. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). The American Journal of Cardiology. 2019;124(9):1406–12. DOI: 10.1016/j.amjcard.2019.07.046

6. Alonso-Ventura V, Campos-Magallon P, Moreno-Franco B, Calmarza P, Calvo-Gracia F, Lou-Bonafonte JM et al. An elevated parametric thyroid feedback quantile-based index is associated with atrial fibrillation. Frontiers in Endocrinology. 2023;14:1087958. DOI: 10.3389/fendo.2023.1087958

7. Li J, Liu Z, Zhao H, Yun F, Liang Z, Wang D et al. Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats. Endocrine. 2019;65(2):338–47. DOI: 10.1007/s12020-019-01968-z

8. Tribulova N, Kurahara LH, Hlivak P, Hirano K, Szeiffova Bacova B. Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism. International Journal of Molecular Sciences. 2020;21(8):2844. DOI: 10.3390/ijms21082844

9. Rakhmatullov R.F., Mel’nikova L.V., Moiseeva I.Ya., Rakhmatul lov F.K. A pharmacotherapy of atrial fibrillation in subclinical thyrotoxicosis. University proceedings. Volga region. Medical sciences. 2021;2(58):35–48. DOI: 10.21685/2072-3032-2021-2-4

10. Tsareva Yu.O., Mayskova E.A., Fedotov E.A., Shvarts Yu.G. Circadian rhythms of thyroid hormones in patients with ischemic heart disease, arterial hypertension, and atrial fibrillation. Kardiologiia. 2019;59(3S):23–9. DOI: 10.18087/cardio.2506

11. Naumova M.V., Babaeva A.R., Davydov S.I. Analysis of risk factors of atrial fibrillation in endocrinopathies. Medical alphabet. 2023;30:19–23. DOI: 10.33667/2078-5631-2022-30-19-23

12. Aguilar M, Rose RA, Takawale A, Nattel S, Reilly S. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation. Cardiovascular Research. 2021;117(7):1645–61. DOI: 10.1093/cvr/cvab080